Comments
The all-important technical review of Bharat Biotech’s Covaxin, by the World Health Organization (WHO), is expected this week. It is keenly watched by many in India, because their travel plans depend on the WHO’s ‘emergency use listing’ of this Covid-19 vaccine. Youngsters who are looking to study abroad and have taken Covaxin are hoping the WHO’s approval comes through, as several countries including the US have said they would recognise vaccines approved by the WHO. Despite several public health voices protesting the requirement of vaccination as a licence to travel, the practice continues across several countries.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.